Skip to content
Catalyst

Carthamus tinctoriusFinding

Carthamus tinctorius increases clinical effective rate (composite responder rate)

raisesModerate evidenceFinding

01 · The sentence it was drawn from

“The results suggested that the total efficacy rate in safflower yellow adjuvant to conventional treatment group was higher than that in conventional treatment group (RR = 1.28, 95%CI 1.21 to 1.36; Fig. 3E).”
Quoted verbatim from Comparative study of safflower yellow adjuvant to conventional treatment regimen and conventional treatment regimen on diabetic nephropathy.
This finding among the 3 findings on its endpoint

Carthamus tinctorius

Clinical effective rate (composite responder rate)

raises

Effect as reported

1.28risk ratio

CI 1.21 to 1.36

Who
Patients with early diabetic nephropathy and type 2 diabetes; 15 pooled randomised trials of safflower yellow added to conventional treatment versus conventional treatment, with background drugs given to both arms in many trials
Dose studied
not reported

Moderate evidencePMID 39256461 · 2024

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7M0X2DWZ4QW4T23TNEAMPXC